BYSI
Price
$2.45
Change
-$0.07 (-2.78%)
Updated
Jun 27 closing price
Capitalization
97.16M
68 days until earnings call
VSTM
Price
$4.15
Change
-$0.01 (-0.24%)
Updated
Jun 27 closing price
Capitalization
228.04M
Interact to see
Advertisement

BYSI vs VSTM

Header iconBYSI vs VSTM Comparison
Open Charts BYSI vs VSTMBanner chart's image
BeyondSpring
Price$2.45
Change-$0.07 (-2.78%)
Volume$33.03K
Capitalization97.16M
Verastem
Price$4.15
Change-$0.01 (-0.24%)
Volume$5.15M
Capitalization228.04M
BYSI vs VSTM Comparison Chart in %
Loading...
BYSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BYSI vs. VSTM commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BYSI is a Hold and VSTM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (BYSI: $2.45 vs. VSTM: $4.15)
Brand notoriety: BYSI and VSTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BYSI: 42% vs. VSTM: 223%
Market capitalization -- BYSI: $97.16M vs. VSTM: $228.04M
BYSI [@Biotechnology] is valued at $97.16M. VSTM’s [@Biotechnology] market capitalization is $228.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BYSI’s FA Score shows that 0 FA rating(s) are green whileVSTM’s FA Score has 0 green FA rating(s).

  • BYSI’s FA Score: 0 green, 5 red.
  • VSTM’s FA Score: 0 green, 5 red.
According to our system of comparison, BYSI is a better buy in the long-term than VSTM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BYSI’s TA Score shows that 4 TA indicator(s) are bullish while VSTM’s TA Score has 3 bullish TA indicator(s).

  • BYSI’s TA Score: 4 bullish, 5 bearish.
  • VSTM’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BYSI is a better buy in the short-term than VSTM.

Price Growth

BYSI (@Biotechnology) experienced а -22.71% price change this week, while VSTM (@Biotechnology) price change was -15.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

BYSI is expected to report earnings on Sep 05, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VSTM($228M) has a higher market cap than BYSI($97.2M). BYSI YTD gains are higher at: 50.307 vs. VSTM (-19.729). BYSI has higher annual earnings (EBITDA): -9.01M vs. VSTM (-145.04M). VSTM has more cash in the bank: 118M vs. BYSI (8.53M). BYSI has less debt than VSTM: BYSI (547K) vs VSTM (76.8M). VSTM has higher revenues than BYSI: VSTM (10M) vs BYSI (0).
BYSIVSTMBYSI / VSTM
Capitalization97.2M228M43%
EBITDA-9.01M-145.04M6%
Gain YTD50.307-19.729-255%
P/E RatioN/AN/A-
Revenue010M-
Total Cash8.53M118M7%
Total Debt547K76.8M1%
FUNDAMENTALS RATINGS
BYSI vs VSTM: Fundamental Ratings
BYSI
VSTM
OUTLOOK RATING
1..100
4450
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
81
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
3665
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BYSI's Valuation (57) in the Pharmaceuticals Major industry is in the same range as VSTM (81) in the Biotechnology industry. This means that BYSI’s stock grew similarly to VSTM’s over the last 12 months.

BYSI's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as VSTM (100) in the Biotechnology industry. This means that BYSI’s stock grew similarly to VSTM’s over the last 12 months.

BYSI's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as VSTM (100) in the Biotechnology industry. This means that BYSI’s stock grew similarly to VSTM’s over the last 12 months.

BYSI's Price Growth Rating (36) in the Pharmaceuticals Major industry is in the same range as VSTM (65) in the Biotechnology industry. This means that BYSI’s stock grew similarly to VSTM’s over the last 12 months.

BYSI's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as VSTM (100) in the Biotechnology industry. This means that BYSI’s stock grew similarly to VSTM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BYSIVSTM
RSI
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 17 days ago
86%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BYSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TWODY17.240.36
+2.14%
Taylor Wimpey Plc
RGRNF3.10N/A
N/A
Regis Resources NL
BDORY4.03-0.05
-1.23%
Banco Do Brasil SA
NTCPF0.82-0.06
-6.47%
Northisle Copper & Gold Inc.
NSGCF0.02N/A
-9.37%
NORTHSTAR GOLD CORP.

BYSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BYSI has been loosely correlated with PHGE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BYSI jumps, then PHGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BYSI
1D Price
Change %
BYSI100%
-2.78%
PHGE - BYSI
39%
Loosely correlated
-2.22%
APGE - BYSI
34%
Loosely correlated
N/A
DOSEF - BYSI
27%
Poorly correlated
N/A
SNPX - BYSI
27%
Poorly correlated
+23.37%
VSTM - BYSI
26%
Poorly correlated
-0.24%
More

VSTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, VSTM has been loosely correlated with GNLX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if VSTM jumps, then GNLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VSTM
1D Price
Change %
VSTM100%
-0.24%
GNLX - VSTM
48%
Loosely correlated
-1.97%
SNSE - VSTM
46%
Loosely correlated
+3.58%
NKTX - VSTM
41%
Loosely correlated
-3.18%
IPSC - VSTM
41%
Loosely correlated
-5.74%
SYRE - VSTM
40%
Loosely correlated
-4.99%
More